References
- Gartaganis S, Ismiridis K, Papageorgiou O, Beratis NG, Papanastasiou D. Ocular abnormalities in patients with beta-thalassemia. Am J Ophtalmology. 1989; 108:699-703. Google Scholar
- Sorcinelli R, Sitzia A, Figus M, Lai ME. Ocular findings in beta thalassemia. Metabolic Pediatric and Systemic Ophtalmology. 1990; 13:23-25. Google Scholar
- Bloomfeld SE, Markenson AL, Miller DR, Peterson CM. Lens opacities in thalassemia. J Ped Ophtalmol Strabismus. 1978; 15:154-156. Google Scholar
- De Virgilis S, Congia M, Turco MP, Frau F, Dessi C, Argiolu F. Depletion of trace elements and acute ocular toxicity induced by deferoxamine in patients with thalassemia. Arch Dis Child. 1988; 63:250-55. Google Scholar
- Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L. A Phase III Study of deferasirox (ICL670), a once daily oral iron chelator in patients with beta-Thalassemia. Blood. 2006; 107:3455-62. Google Scholar
- Wegener A, Laser H. Image analysis and Scheimpflug photography of anterior segment of the eye: a review. Klin Monatsbl Augenheilkd. 2001; 218:67-77. Google Scholar
- Davies SC, Hungerford JL, Arden GB, Marcus RE, Miller MH, Huehns ER. Ocular toxicity of high dose intravenous desferrioxamine. Lancet. 1983; 2:181-4. Google Scholar
- Deferasirox- Novartis Investigator’s Brochure. 2006;22. Google Scholar